Elevate Holistics Has Launched Ketamine Telehealth Platform
The service connects patients in select states to virtual evaluations and medication for mental health support.
Updated on Oct. 5, 2026 in Substance Abuse
Live Poll
Do you trust online telehealth platforms to provide safe medical oversight for specialized mental health treatment?
Elevate Holistics has introduced a new online platform offering low-dose ketamine treatment in Arizona, Florida, Missouri, Oklahoma, and Washington. The model includes virtual provider evaluations, behavioral health support, and medication fulfillment for individuals seeking new treatment options.
Why it matters
This platform provides an additional care path for people who have not achieved desired results through other mental health approaches. It expands access to supervised ketamine therapy by integrating telehealth with licensed pharmacy fulfillment.
A 2024 Phase 2 study reported a 72.7% response rate for patients using extended-release ketamine tablets. These findings suggest potential efficacy for this intervention, though further large-scale research is still required to confirm long-term clinical benefits.
The players
Elevate Holistics
A company previously focused on medical cannabis access that has now expanded into virtual mental health services.
Food and Drug Administration
The federal agency responsible for regulating medications and approving therapeutic uses for pharmaceutical agents.
The details
Patients begin with an online health screening and a formal telehealth evaluation with a licensed provider to determine eligibility. If cleared, participants complete a one-hour behavioral health onboarding session before receiving medication, which involves a schedule of approximately 16 doses per month. Prescriptions are fulfilled through licensed compounding pharmacies, utilizing ketamine, which was originally approved by the FDA as an anesthetic in 1970.
Timeline
1970: FDA approved ketamine as an anesthetic.
2024: A study on ketamine tablets was published in Nature Medicine.
October 4, 2026: Elevate Holistics launched its ketamine telehealth platform.
Health Landscape
This development follows recent clinical interest surrounding the potential of ketamine for mental health conditions, as evidenced by the 2024 Nature Medicine ketamine tablet study. It represents a shift toward expanding specialized, virtual-first access to treatments beyond traditional clinic settings.
If you are exploring new options for mental health support, review the eligibility criteria and discuss the potential benefits and risks of low-dose ketamine with your primary care physician. It is essential to ensure that any virtual care platform provides appropriate oversight and behavioral support.
The takeaway
Telehealth platforms are increasingly offering specialized mental health interventions like low-dose ketamine for patients who have not responded to other treatments. Always consult your physician to determine if these emerging therapies align with your specific medical history and health goals.
What happens next
Elevate Holistics plans to expand its telehealth services into additional U.S. states in the future.
Further reading
For more on evolving mental health care models, visit Substance Abuse.
More information
Review the full ketamine care information and eligibility details on the provider website.
Live Poll
Do you trust online telehealth platforms to provide safe medical oversight for specialized mental health treatment?
